PHARMACEUTICAL FORMULATION COMPRISING LOSARTAN POTASSIUM AND CHLORTHALIDONE

World Intellectual Property Organization Patent

APP PUB NO WO-2015078804-A1
SERIAL NO

PCTEP2014075371

Stats

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention is a pharmaceutical tablet formulation comprising between about 2.5 mg and 100 mg losartan potassium, between about 6.25 mg and about 50 mg chlorthalidone, and sodium bicarbonate in an amount between about 1.0% and about 10.0% by weight.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERCK SHARP & DOHMENLWAARDERWEG 39 2031 BN HAARLEM NL

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address
FALIVENE ALDEA ALBERT NL-5340 BH OSS
WIJGERGANGS JAN-PIET NL-5340 BH OSS
ZWINKELS JOCOMINUS ANTONIUS MARIA NL-5340 BH OSS

Cited Art Landscape

Load Citation